{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_0", "document_index": 290, "latency_s": 1.0878060000104597, "prompt_toks": 1910, "completion_toks": 64}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    drug: Oxycodone\npsychonaut_name: Oxycodone\npsychonaut_url: https://psychonautwiki.org/wiki/Oxycodone\n\n\n                    Context: \n                    This chunk provides the basic identification details and URL for the drug Oxycodone, serving as a brief summary within the broader document that discusses its pharmacological effects, chemistry, and legal status. It is essential for referencing and quick access to the main source of information about Oxycodone on psychonautwiki.org.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_1", "document_index": 290, "latency_s": 0.7971000999968965, "prompt_toks": 2209, "completion_toks": 66}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Infobox: Oxycodone | Chemical Nomenclature | Common names | OxyContin, Oxy, Roxicodone, Oxecta, OxyIR, Endone, Oxynor, Codilek, Oxydor, Redocam, Oxygesic, Percodan, Percocet | Substitutive name | Oxycodone | Systematic name | (5R,9R,13S,14S)-4,5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one | Class Membership | Psychoactive class | Opioid | Chemical class | Morphinan | Routes of Administration | WARNING: | Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. | See responsible use section | . | ⇣ | Smoked | Dosage | Bioavailability | ~85-90% (estimated, not accurate, needs confirmation) | Threshold | 1 mg | Light | 1.5 - 8mg | Common | 8 | - | 20mg | Strong | 20 | - | 35mg | Heavy | 30 | mg + | Duration | Total | 1 - 3 hours | ⇣ | Oral | Dosage | Bioavailability | 60-70% | [2] | Threshold | 1 mg | Light | 2.5 - 10 mg | Common | 10 - 25 mg | Strong | 25 - 40 mg | Heavy | 40 mg + | Duration | Total | 4 -\n\n\n                    Context: \n                    This chunk is an excerpt from the infobox section of the Oxycodone webpage, providing detailed chemical, nomenclature, common names, and dosage information. It summarizes key pharmacological data, routes of administration, bioavailability, and potency levels, serving as a quick-reference summary of essential drug characteristics within the full article.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_2", "document_index": 290, "latency_s": 0.8648326999973506, "prompt_toks": 2236, "completion_toks": 69}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    | 1 - 3 hours | ⇣ | Oral | Dosage | Bioavailability | 60-70% | [2] | Threshold | 1 mg | Light | 2.5 - 10 mg | Common | 10 - 25 mg | Strong | 25 - 40 mg | Heavy | 40 mg + | Duration | Total | 4 - 8 hours | Onset | 20 - 40 minutes | Peak | 4 - 6 hours | Offset | 0 - 2 hours | ⇣ | Insufflated | Dosage | Bioavailability | ~77% | [3] | Threshold | 1 mg | Light | 2.5 - 7.5 mg | Common | 7.5 - 15 mg | Strong | 15 - 25 mg | Heavy | 25 mg + | Duration | Total | 3 - 5 hours | Onset | 2 - 7 minutes | Come up | 20 | - | 40 | minutes | Peak | 1.5 - 4 hours | Offset | 45 - 120 | minutes | ⇣ | Intravenous | Dosage | Bioavailability | 100% | Threshold | 1 mg | Light | 2.5 - 5 mg | Common | 7.5 - 10 mg | Strong | 12.5 - 15 mg | Heavy | 15 mg + | Duration | Total | 3 - 5 hours | Onset | 0 - 1 minutes | Peak | 3 - 5 hours | DISCLAIMER | : | PW's | dosage | information is gathered from users and | resources | for educational purposes only. It is not a recommendation and should be verified with other\n\n\n                    Context: \n                    This chunk provides detailed dosage and administration information for oxycodone across various routes (oral, insufflation, intravenous), including bioavailability percentages, dosage thresholds, durations, onset times, and peak effects. It complements the overall document by offering specific pharmacokinetic data crucial for understanding oxycodone's effects and responsible use.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_3", "document_index": 290, "latency_s": 0.9535871000116458, "prompt_toks": 1972, "completion_toks": 77}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Peak | 3 - 5 hours | DISCLAIMER | : | PW's | dosage | information is gathered from users and | resources | for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. | Interactions | MAOIs | Nitrous | PCP | Stimulants | Alcohol | Benzodiazepines | DXM | GHB | GBL | Ketamine | MXE | Tramadol | Grapefruit\n\n\n                    Context: \n                    This chunk provides detailed information on the peak duration (3-5 hours) of oxycodone's effects, along with important dosage disclaimers, safety warnings, and potential drug interactions such as MAOIs, stimulants, and alcohol. It enhances the comprehensive pharmacological and safety overview within the full document essential for understanding oxycodone’s timing and risk factors.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_4", "document_index": 290, "latency_s": 1.9627059000049485, "prompt_toks": 1919, "completion_toks": 56}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Summary: \nContents: \nChemistry: \nPharmacology: \nSubjective effects: \nToxicity and harm potential: \nLegal status: \nSee also: \nExternal links: \nReferences:\n\n\n                    Context: \n                    This chunk outlines the main sections of the webpage related to Oxycodone, including chemistry, pharmacology, subjective effects, toxicity, legal status, and references, serving as an overview of the detailed information provided in the full document on its effects, risks, and legal considerations.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_5", "document_index": 290, "latency_s": 0.9648708000022452, "prompt_toks": 2072, "completion_toks": 80}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Physical effects: - Pain relief Euphoria - In comparison to other opioids , this particular substance can be considered similar in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as extreme feelings of intense physical comfort, warmth, love and bliss. Respiratory depression - At low to moderate doses, this effect results in the sensation that the breath is slowed down mildly to moderately, but does not cause noticeable impairment. At high doses and overdoses, opioid-induced respiratory depression can result in a shortness of breath, abnormal breathing patterns, semi-consciousness, or unconsciousness. Severe overdoses can result in a coma or death without immediate medical attention. Sedation - Oxycodone is considerably less sedating than codeine but more sedating than kratom . Constipation Cough suppression Decreased libido Difficulty urinating\n\n\n                    Context: \n                    This chunk summarizes key physical effects of oxycodone, including pain relief, euphoria, respiratory depression, sedation, and common side effects like constipation and nausea. It provides detailed descriptions of the intensity and risks at various dosages, supplementing the comprehensive pharmacology and effects overview in the full document. These details are crucial for understanding oxycodone's physical impact and safety profile.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_6", "document_index": 290, "latency_s": 0.6644662000035169, "prompt_toks": 1952, "completion_toks": 66}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    immediate medical attention. Sedation - Oxycodone is considerably less sedating than codeine but more sedating than kratom . Constipation Cough suppression Decreased libido Difficulty urinating Itchiness Nausea - This effect is more pronounced at higher doses. Pupil constriction Stomach cramps Appetite suppression Orgasm suppression Increased perspiration Skin flushing\n\n\n                    Context: \n                    This excerpt summarizes the physical effects and side effects of oxycodone, highlighting its analgesic and euphoric properties, as well as common adverse effects such as sedation, constipation, nausea, and pupil constriction, which are relevant to understanding the drug's pharmacology and safety profile discussed in the full document.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_7", "document_index": 290, "latency_s": 0.9457016999949701, "prompt_toks": 2080, "completion_toks": 74}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Pain relief\n- Euphoria - In comparison to other opioids , this particular substance can be considered similar in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as extreme feelings of intense physical comfort, warmth, love and bliss.\n- Respiratory depression - At low to moderate doses, this effect results in the sensation that the breath is slowed down mildly to moderately, but does not cause noticeable impairment. At high doses and overdoses, opioid-induced respiratory depression can result in a shortness of breath, abnormal breathing patterns, semi-consciousness, or unconsciousness. Severe overdoses can result in a coma or death without immediate medical attention.\n- Sedation - Oxycodone is considerably less sedating than codeine but more sedating than kratom .\n- Constipation\n- Cough suppression\n- Decreased libido\n- Difficulty urinating\n\n\n                    Context: \n                    This excerpt summarizes the key physical and subjective effects of oxycodone, including pain relief, euphoria, respiratory depression, sedation, and side effects such as constipation and urinary issues. It provides essential information on oxycodone’s potency, comparison to other opioids, and its typical physiological impact, serving as a core overview within the full pharmacological profile.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_8", "document_index": 290, "latency_s": 1.024147100004484, "prompt_toks": 1971, "completion_toks": 91}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Sedation - Oxycodone is considerably less sedating than codeine but more sedating than kratom .\n- Constipation\n- Cough suppression\n- Decreased libido\n- Difficulty urinating\n- Itchiness\n- Nausea - This effect is more pronounced at higher doses.\n- Pupil constriction\n- Stomach cramps\n- Appetite suppression\n- Orgasm suppression\n- Increased perspiration\n- Skin flushing\n\n\n                    Context: \n                    This section lists common physical side effects and physiological responses associated with oxycodone use, complementing the document's detailed discussion of its effects, toxicity, and pharmacology. It highlights symptoms such as sedation, constipation, nausea, and respiratory-related effects, providing essential information for understanding oxycodone's impact on the body. These effects are critical for users, healthcare professionals, and researchers seeking comprehensive data on oxycodone's profile.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_9", "document_index": 290, "latency_s": 1.071365900003002, "prompt_toks": 2077, "completion_toks": 74}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Skin flushing\nCognitive effects: - Euphoria - This seems to be caused by both µ-opioid receptor agonism and downstream dopamine reinforcement. In comparison to other opioids , this particular substance can be considered similar in its cognitive euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as powerful and overwhelming feelings of emotional bliss, contentment, and happiness. Ego inflation Anxiety suppression Irritability - While opioids are well known for their ability to improve mood, they can also have the paradoxical effect of increasing the user's sensitivity to irritable stimuli. This can manifest as aloofness and sudden outbursts of anger and aggression (colloquially known as \"opiate rage\"). It appears to occur more frequently during the comedown of the experience and/or with heavy use. Compulsive redosing Dream potentiation Increased music appreciation\n\n\n                    Context: \n                    This chunk details the cognitive effects of oxycodone, highlighting its euphoric and mood-altering properties, including feelings of bliss, anxiety suppression, irritability, and potential for \"opiate rage.\" It expands on the drug’s psychological impact, complementing the physical effects section, and provides important information for understanding oxycodone's mental and emotional influence.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_10", "document_index": 290, "latency_s": 0.8858125000115251, "prompt_toks": 2083, "completion_toks": 61}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Euphoria - This seems to be caused by both µ-opioid receptor agonism and downstream dopamine reinforcement. In comparison to other opioids , this particular substance can be considered similar in its cognitive euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as powerful and overwhelming feelings of emotional bliss, contentment, and happiness.\n- Ego inflation\n- Anxiety suppression\n- Irritability - While opioids are well known for their ability to improve mood, they can also have the paradoxical effect of increasing the user's sensitivity to irritable stimuli. This can manifest as aloofness and sudden outbursts of anger and aggression (colloquially known as \"opiate rage\"). It appears to occur more frequently during the comedown of the experience and/or with heavy use.\n- Compulsive redosing\n- Dream potentiation\n- Increased music appreciation\nHistory and culture:\n\n\n                    Context: \n                    This excerpt details the cognitive and emotional effects of oxycodone, highlighting its euphoric qualities, mood-altering potential, and paradoxical effects like irritability and anxiety suppression; it is situated within the broader pharmacology section of the document, providing insights into its subjective mental states and behavioral impacts.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 61, "doc_id": "doc_290", "num_chunks": 12, "chunk_id": "290::chunk_11", "document_index": 290, "latency_s": 0.7139062999922317, "prompt_toks": 2041, "completion_toks": 77}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Compulsive redosing\n- Dream potentiation\n- Increased music appreciation\nHistory and culture: \nLiterature: \nVisual effects: - Internal hallucination - One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery and mild geometry .\n- Internal hallucination - One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery and mild geometry .\nAuditory effects: \nMulti-sensory effects: \nTranspersonal effects: \nDisconnective effects: \nAfter effects: \nReagent results: \nPreparation methods: \nResearch: \nExamples: \nLegal issues: \nParadoxical effects: \nOther:\n\n\n                    Context: \n                    This excerpt details subjective and perceptual effects of oxycodone, including hallucinations, dream states, and sensory enhancements, as well as cultural and historical contexts. It provides specific insights into visual and auditory effects experienced at high doses, along with potential after-effects and related research considerations. These details are crucial for understanding oxycodone’s psychoactive profile and its impact on perception.\n                "}
